Histopathological characterization of cerebral small vessel disease in epilepsy patients with temporal lobe epilepsy submitted to surgery : A case-control study
© 2023 European Academy of Neurology..
BACKGROUND: Cerebrovascular disease (CVD) is a major contributor to epilepsy; however, patients with epilepsy also have a significantly increased risk of stroke. The way in which epilepsy contributes to the increased risk of stroke is still uncertain and is ill-characterized in neuropathological studies. A neuropathological characterization of cerebral small vessel disease (cSVD) in patients with chronic epilepsy was performed.
METHODS: Thirty-three patients with refractory epilepsy and hippocampal sclerosis (HS) submitted to epilepsy surgery from a reference center were selected between 2010 and 2020 and compared with 19 autopsy controls. Five randomly selected arterioles from each patient were analyzed using a previously validated scale for cSVD. The presence of CVD disease imaging markers in pre-surgical brain magnetic resonance imaging (MRI) was studied.
RESULTS: There were no differences in age (43.8 vs. 41.6 years; p = 0.547) or gender distribution (female gender 60.6% vs. male gender 52.6%; p = 0.575) between groups. Most CVD findings in brain MRI were mild. Patients had a mean time between the epilepsy onset and surgery of 26 ± 14.7 years and were medicated with a median number of three antiseizure medication (ASMs) [IQR 2-3]. Patients had higher median scores in arteriolosclerosis (3 vs. 1; p < 0.0001), microhemorrhages (4 vs. 1; p < 0.0001) and total score value (12 vs. 8.9; p = 0.031) in comparison with controls. No correlation was found between age, number of years until surgery, number of ASMs or cumulative defined daily dosage of ASM.
CONCLUSION: The present study provides evidence supporting the increased burden of cSVD in the neuropathological samples of patients with chronic epilepsy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
European journal of neurology - 30(2023), 10 vom: 28. Okt., Seite 2999-3007 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Coelho, Pedro [VerfasserIn] |
---|
Links: |
---|
Themen: |
Atherosclerosis |
---|
Anmerkungen: |
Date Completed 08.09.2023 Date Revised 11.09.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/ene.15963 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM359034020 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM359034020 | ||
003 | DE-627 | ||
005 | 20231226080014.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/ene.15963 |2 doi | |
028 | 5 | 2 | |a pubmed24n1196.xml |
035 | |a (DE-627)NLM359034020 | ||
035 | |a (NLM)37402214 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Coelho, Pedro |e verfasserin |4 aut | |
245 | 1 | 0 | |a Histopathological characterization of cerebral small vessel disease in epilepsy patients with temporal lobe epilepsy submitted to surgery |b A case-control study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.09.2023 | ||
500 | |a Date Revised 11.09.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 European Academy of Neurology. | ||
520 | |a BACKGROUND: Cerebrovascular disease (CVD) is a major contributor to epilepsy; however, patients with epilepsy also have a significantly increased risk of stroke. The way in which epilepsy contributes to the increased risk of stroke is still uncertain and is ill-characterized in neuropathological studies. A neuropathological characterization of cerebral small vessel disease (cSVD) in patients with chronic epilepsy was performed | ||
520 | |a METHODS: Thirty-three patients with refractory epilepsy and hippocampal sclerosis (HS) submitted to epilepsy surgery from a reference center were selected between 2010 and 2020 and compared with 19 autopsy controls. Five randomly selected arterioles from each patient were analyzed using a previously validated scale for cSVD. The presence of CVD disease imaging markers in pre-surgical brain magnetic resonance imaging (MRI) was studied | ||
520 | |a RESULTS: There were no differences in age (43.8 vs. 41.6 years; p = 0.547) or gender distribution (female gender 60.6% vs. male gender 52.6%; p = 0.575) between groups. Most CVD findings in brain MRI were mild. Patients had a mean time between the epilepsy onset and surgery of 26 ± 14.7 years and were medicated with a median number of three antiseizure medication (ASMs) [IQR 2-3]. Patients had higher median scores in arteriolosclerosis (3 vs. 1; p < 0.0001), microhemorrhages (4 vs. 1; p < 0.0001) and total score value (12 vs. 8.9; p = 0.031) in comparison with controls. No correlation was found between age, number of years until surgery, number of ASMs or cumulative defined daily dosage of ASM | ||
520 | |a CONCLUSION: The present study provides evidence supporting the increased burden of cSVD in the neuropathological samples of patients with chronic epilepsy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a atherosclerosis | |
650 | 4 | |a cerebral small vessel disease | |
650 | 4 | |a epilepsy | |
650 | 4 | |a hippocampal sclerosis | |
650 | 4 | |a neuropathology | |
650 | 4 | |a stroke | |
700 | 1 | |a Madureira, João |e verfasserin |4 aut | |
700 | 1 | |a Franco, Ana |e verfasserin |4 aut | |
700 | 1 | |a Peralta, Ana Rita |e verfasserin |4 aut | |
700 | 1 | |a Bentes, Carla |e verfasserin |4 aut | |
700 | 1 | |a Campos, Alexandre Rainha |e verfasserin |4 aut | |
700 | 1 | |a Anink, Jasper |e verfasserin |4 aut | |
700 | 1 | |a Aronica, Eleonora |e verfasserin |4 aut | |
700 | 1 | |a Roque, Rafael |e verfasserin |4 aut | |
700 | 1 | |a Pimentel, José |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of neurology |d 1994 |g 30(2023), 10 vom: 28. Okt., Seite 2999-3007 |w (DE-627)NLM094480362 |x 1468-1331 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2023 |g number:10 |g day:28 |g month:10 |g pages:2999-3007 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/ene.15963 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 30 |j 2023 |e 10 |b 28 |c 10 |h 2999-3007 |